Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance.

Saved in:
Bibliographic Details
Title: Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance.
Authors: Jane EP; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Premkumar DR; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania. daniel.premkumar@chp.edu ian.pollack@chp.edu.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania., Thambireddy S; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania., Golbourn B; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania., Agnihotri S; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania., Bertrand KC; Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Mack SC; Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Myers MI; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania., Chattopadhyay A; Molecular Biology Information Service, University of Pittsburgh, Pittsburgh, Pennsylvania., Taylor DL; Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Schurdak ME; Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Stern AM; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Pollack IF; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania. daniel.premkumar@chp.edu ian.pollack@chp.edu.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania.
Source: Molecular cancer research : MCR [Mol Cancer Res] 2020 Jul; Vol. 18 (7), pp. 1004-1017. Date of Electronic Publication: 2020 Apr 01.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3125
DOI:10.1158/1541-7786.MCR-19-0669